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Abstract:  
Rheumatoid arthritis (RA) is characterized by the presence of anti-citrullinated peptide 
antibodies (ACPAs) and neutrophils infiltrating the synovial fluid (SF) of the affected joints. 
The aim of this work was to analyze whether the presence of ACPAs in SF is associated with 
neutrophil infiltration and with their phenotype in the inflamed joints of RA patients. We 
found that in the presence of ACPAs, the number of synovial neutrophils correlated with 
severe disease activity. The SF were divided according to synovial ACPA levels in negative-
(<25 U/ml), low-(25-200 U/ml) and high level (˃200 U/ml; ACPAhigh). We observed that IL-
6, IL-17 and IL-8 were significantly elevated in ACPA
high
SF and that IL-8 levels correlated 
positively with neutrophil counts and with worse clinical manifestations. Additionally, in 
vitro incubation of neutrophils with ACPA
high
 SF resulted in an increased ROS production 
and extracellular DNA release compared to neutrophils incubated with ACPA-negative SF. 
These exacerbated effector functions were associated with a fraction of ICAM-1-positive 
neutrophils, which were induced by ACPA
high
 SF. Likewise, in in vivo, we could also detect 
this subset among neutrophils present in ACPA
high
 SF. In conclusion, the data presented here 
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shed light on the role of SF-ACPAs as inductors of a pro-inflammatory profile in neutrophils.  
 
 
Introduction:  
Rheumatoid arthritis (RA) is a systemic inflammatory disease that manifests itself in 
persistent synovial inflammation, leukocyte infiltration and immune activation, which can 
cause cartilage and bone damage and long term disability [1]. Although the pathogenetic 
events initiating and mediating chronicity of synovitis are not yet fully understood, there are 
many of inflammatory cells accumulated in the synovial fluid (SF) and involved in its 
pathogenesis [1]. In the specific case of neutrophils, they can be found at large numbers 
either in the SF of the affected joints or in the pannus/cartilage interface and they have the 
greatest potential to cause damage [2-4]. 
Patients with RA are characterized by presenting some circulating autoantibodies in their 
serum. Among the numerous autoantibodies associated with RA, anti-cyclic citrullinated 
peptide antibodies (ACPAs) are now recognized as the most disease-specific [5]. The 
presence of these antibodies, together with the autoantibodies rheumatoid factor (RF), 
permits the disease classification into seropositive or seronegative forms. The two RA subsets 
have different disease manifestations, with the seropositive status associated with poor 
outcomes, such as increased disease activity, radiographic progression and disability [6]. 
Although the presence of ACPAs is associated with an aggressive disease course and, thus, 
can guide clinical practice, the specific role of autoantibody levels is still unclear [5-6].  
Neutrophils are now recognized as major orchestrators of inflammation and as deeply 
influencing other cells from the innate and adaptive immune system [4]. Excessive neutrophil 
activation can result in severe tissue damage and chronic inflammation through the release of 
cytotoxic reactive oxygen species (ROS), tissue-damaging molecules and proteases, 
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neutrophil extracellular traps (NETs), and inflammatory cytokines and chemokines. It is well 
established that neutrophils play a relevant role in RA [2]. NETs were identified as a source 
of peptidyl arginine deiminases (PAD) as well as citrullinated proteins [7-8]. In addition, 
neutrophils are one of the few cells expressing high levels of PAD4, which is the main 
enzyme responsible for the citrullination of peptides [10]. Thus, neutrophils have a central 
role in the production of autoantigens, this phenomenon being a key stage in the autoimmune 
response in ACPA‐positive patients with RA [9-10]. 
The contribution of neutrophils to the pathology of RA has not been completely elucidated. 
The aim of this work was to analyze whether the presence of ACPAs in SF is associated with 
neutrophil infiltration as well as with the phenotype of these cells in the inflamed joints of 
RA patients. We present data showing the effect of SF-ACPA on neutrophil recruitment in 
vivo and also the effect of different levels of these autoantibodies in SF on neutrophil 
response and phenotype in vitro. 
 
Results 
Relationship between neutrophil counts and disease activity in synovial ACPA-positive 
patients 
ACPAs were found in the serumof most patients with established RA. It is believed that 
ACPA positive and ACPA negative RA may define two different disease entities [5]. Several 
studies have shown that ACPA-positive RA patients develop earlier and more widely spread 
erosions than consistently ACPA-negative patients. For this reason, we first sought to 
determine whether the presence of synovial ACPAs is associated with neutrophilic infiltrates 
in the SF of RA patients. Although neutrophil counts did not differ significantly between 
synovial ACPA-positive and ACPA-negative patients (p=0.11), it was observed that in the 
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presence of SF-ACPAsthe number of neutrophils infiltrating inflamed joints correlated with 
severe disease activity score (DAS-28) (p=0.02; n=42). Surprisingly, this was not the case for 
synovial ACPA-negative patients (p=0.36; n=21) (Figure 1A). Differences were not found 
either in clinical characteristics or in treatments between both groups of 
patients(Supplemental Table 1). Therefore, this did not influence neutrophilic infiltrates. 
Next, the association of the clinical parameter DAS-28 with ACPA titers and total 
Immunoglobulin G (IgG) levels in the SF of synovial ACPA-positive patients was examined. 
As shown in Figure 1B, total IgG levelsnegatively correlated with DAS-28. A direct 
relationship between SF-ACPA titers and DAS-28 score was not found (data not shown). 
However, the correction of ACPA concentration in SF by the ratio ACPA/total IgG showed a 
positive correlation with disease activity (p=0.03), indicating that ACPA levels are increased 
in relation to total IgG in SF from patients with more serious clinical manifestations. 
 
Differential levels of pro-inflammatory cytokines according to SF-ACPA concentrations 
It is well established that cytokines are directly implicated in many of the immune processes 
associated with the pathogenesis of RA [1]. Among pro-inflammatory cytokines, IL-1β, TNF-
α, IL-6, IL-8, IL-23 and IL-17 can be detected in SF of RA patients and they might promote 
neutrophil activation [2, 11]. Additionally, it has been shown that elevated plasma levels of 
pro-inflammatory cytokines strongly correlate with ACPA titers in plasma of RA patients 
[12]. Therefore the pro-inflammatory cytokine environment which is related with neutrophil 
activity in the SF of our cohort of RA patients was investigated and compared with the 
different synoviallevels of ACPAs. Thus, the SF samples were divided into three groups 
according to ACPA levels in SF: <25 U/ml (negative; ACPA
negative
), 25-200 U/ml (low to 
moderate; ACPA
low) and ˃200 U/ml (high; ACPAhigh). We observed that IL-6, IL-17 and IL-
8 were significantly elevated in SF of patients with ACPA
high
 SF, which are key cytokines 
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implicated in neutrophil activity (Figure 2A). Nevertheless, differences were not found 
regarding the amount of IL-23, TNF-α and IL-1β among ACPA subgroups (Supplementary 
Figure 1).  
 
Levels of IL-8 associated with severe disease activity in SFwith high ACPA titers  
In RA, neutrophils are recruited into the affected joints by chemoattractants and other 
molecules generated during inflammation [2]. IL-8/CXCL8 is a potent chemokine for 
neutrophils and plays a critical role in the recruitment and activation of these cells [13]. 
Considering our previous results in which IL-8 significantly increased in ACPA
high
 SF, we 
next studied the association of this cytokine with neutrophils. Figure 2B shows that in SF 
with high-ACPA titers, neutrophil counts correlated positively with IL-8 levels (p=0.05) 
whereas higher levels of this cytokine were related with more serious clinical manifestations 
(p=0.04).  
 
Increased ROS production and DNA extrusion after stimulation with ACPA
high
 SF  
Release of proteases and ROS have been connected with joint damage via direct oxidation of 
joint components [3]. Given that high levels of ACPAs in SF were related to worse clinical 
manifestations, we examined thepotential contribution of neutrophils to inflammation by 
measuring in vitro ROS production. In order to investigate this phenomenon, the ability of 
neutrophils to release ROS in response to phorbol-12-myristate-13-acetate (PMA) stimulation 
was tested. Peripheral-blood neutrophils from healthy donors were incubated in the presence 
of SF from RA patients with negative, low or high levels of synovial-ACPAs for 3 hours and 
ROS production was assessed by measuring DihidroRhodamine 123 (DHR) fluorescence 
using flow cytometry. Minimal basal ROS production was observed in the absence of PMA, 
although SF samples from RA patients had been previously added (Figure 3A). However, in 
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response to stimulation with PMA, neutrophils incubated with ACPA
high
SF showed an 
increase in ROS production when compared with those incubated with ACPA
negative
 SF 
(Figure 3A). We also tested the effect of autoantibodies and ROS induction. There were no 
differences in the oxidative burst between SF and the fraction of IgG purified from SF. 
Nevertheless, the fraction of SF without IgG was not able to induce ROS, suggesting that the 
presence of autoantibodies on SF is responsible for this effect (Supplementary Figure 2A). As 
neutrophils from RA patients may differ from those from healthy individuals [2], we 
measured ROS production on peripheral-blood neutrophils from RA patients. As previously 
reported [14], we found that RA neutrophils are already primed for oxidative burst and, in 
consequence, it was not necessary to stimulate them with PMA. On the same line as to what 
was shown in PMA-primed neutrophils from healthy individuals, RA neutrophils incubated 
with ACPA
high 
SF showed an increase in ROS production when compared with those 
incubated with ACPA
negative
 SF (Supplementary Figure 2B).  
Given that ROS production is an important step in the formation of NETs, we also measured 
the potential capacity of NET release of SF-treated neutrophils. Quantification of 
extracellular DNA, indicative of NET production, was assessed by fluorometric analysis after 
neutrophil incubation with SF samples. As shown in Figure 3B, incubation of blood 
neutrophils from healthy donors with ACPA
high
 SF resulted in a 6-fold increase of 
extracellular DNA release compared to neutrophils stimulated with ACPA
negative
 SF 
(ACPA
negative
: 39±14 %, ACPA
low
: 170±73 %, ACPA
high
: 226±62 %). Neither the fraction of 
IgG purified from SF nor the fraction of SF without IgG was able to induce DNA extrusion in 
neutrophils from healthy individuals or from RA patients (Supplementary Figure 3A). This 
indicates that the presence of autoantibodies together with other inflammatory components 
was responsible for the DNA release by neutrophils. Additionally, no differences between 
neutrophils from RA patients and those from healthy individuals were found as RA 
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neutrophils with ACPA
high
SF also showed an 8-fold increase in DNA release when compared 
with those incubated with ACPA
negative
 SF (Supplementary Figure 3B).  
All in all, these data suggest that the presence of high levels of SF-ACPAs induces a higher 
production of ROS and extracellular DNA release in RA neutrophils. 
 
High synovial levels of ACPAs and the expression of ICAM-1 on neutrophils  
The data described above suggest that the presence of high ACPA levels in SF has an impact 
on neutrophil functions. To gain more insight into the characteristics of neutrophils after 
exposure of high titres of these autoantibodies in SF, we studied the phenotype of these cells 
by flow cytometry. As the integrin ICAM-1 can be considered as a reference marker found to 
increase in migrated neutrophils [15-16], we decided to evaluate changes in the expression of 
this molecule. We found that incubation of peripheral-blood neutrophils from healthy donors 
with ACPA
high
 SF induced a significant increase in the percentage of ICAM-1-expressing 
neutrophils (Figure 4A). Additionally, this fraction of ICAM-1-positive neutrophils showed a 
decreased expression of the adhesion molecule CD62L and the chemokine receptor CXCR1, 
which were more pronounced after incubation with ACPA
high
 SF, suggesting an activated-cell 
phenotype (Figure 4B). It has been shown that certain stimuli, such as LPS, can induce the 
expression of ICAM-1 on the cell surface of neutrophils [17]. When the induction of ICAM-1 
on neutrophils after LPS or ACPA
high
 SF incubation was compared, differences between 
these stimuli were not found (Supplemental Figure 4A). Moreover, stimulation with IgG 
purified from SF induced a fraction of ICAM-1-positive neutrophils similar to the one 
observed after stimulation with ACPA
high
 SF, showing a direct effect of autoantibodies on the 
induction of the expression of ICAM-1 on neutrophils (Supplemental Figure 4B). Peripheral-
blood neutrophils from RA patients showed the same pattern of induction of ICAM-1 
identified in blood neutrophils from healthy individuals, which excludes the possibility of 
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differences in neutrophil response from RA patients (Supplementary Figure 4C). Considering 
that neutrophils incubated with SF samples with high-ACPA levels favored the formation of 
NETs, the association of enhanced NET release and ICAM-1-positive neutrophils in the 
presence of different SF-ACPA levels was investigated. A correlation between ICAM-1-
positive neutrophils and DNA extrusion was noted in SF with high-ACPA levels (p=0.02) 
(Figure 4C). Collectively, these data provide evidence to suggest that the presence of high 
levels of ACPA in SF induced a fraction of ICAM-1-positive neutrophils which are 
associated with an increased extracellular DNA release. 
 
ICAM-1-positive neutrophils in synovial fluids of RA patients  
Having found that high-ACPA levels in SF induce an up-regulation of ICAM-1 on 
neutrophils, and having related this phenomenon with enhanced effector functions in vitro, 
we next sought to investigate the presence of ICAM-1-positive neutrophils in vivo. To this 
end, freshly SF samples from RA patients were analyzed by flow cytometry (Supplemental 
Figure 5). In agreement with the results found in vitro, ACPA
high
 SF showed a significant 
increase in the percentage of ICAM-1-positive neutrophils (Figure 5A). Furthermore, the 
fraction of ICAM-1-positive neutrophils from patients with high-SF-ACPA levels showed a 
greater decrease in both CD62L and CXCR1 markers, suggesting that these cells might have 
an activated phenotype due to the presence of high titres of these autoantibodies (Figure 5B). 
In conclusion, these results demonstrate that ICAM-1-positive neutrophils are found in SF 
from patients with high synovial levels of ACPAs.  
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Discussion 
There is growing evidence indicating that neutrophils have an active role in the pathogenesis 
of RA [2]. Inflammatory joint effusions of RA patients are characterized by a high number of 
neutrophils in the SF where these cells mediate tissue destruction after improper activation 
[2-4]. The aim of the present study was to analyze the characteristics of neutrophils 
infiltrating the inflamed joints in the presence of ACPA autoantibodies in SF of RA patients. 
We observed that in synovial ACPA-positive patients, the number of SF-neutrophils 
correlates with disease activity and also with IL-8 concentrations in the case of high levels of 
SF-ACPAs. Furthermore, the levels of synovial ACPAs have an impact on ROS production, 
on DNA extracellular release and on the induction of ICAM-1 expression on neutrophils. 
Additionally, our data were further supported by in vivo studies, demonstrating that ICAM-1-
positive neutrophils can be found in the SF of RA patients. 
One of the characteristics of RA is the presence of autoantibodies in the serum of patients [1]. 
Anti-citrullinated protein antibodies comprise a group of highly-specific RA autoantibodies. 
Although the clinical features of ACPA-positive and ACPA-negative patients with RA are 
similar at baseline, the presence of ACPAs is associated with greater radiological joint 
damage [5]. Several studies have focused on synovial differences in RA patients according to 
ACPA status [5], but only few reported the effect of these autoantibodies on the role of 
synovial-neutrophils [7, 18]. In accordance with a previous report, we could not find 
differences in the numbers of synovial-neutrophils in any group of patients [19]. However, 
we observed that neutrophil counts correlated with disease activity in the SF of synovial 
ACPA-positive but not in ACPA-negative patients. Even though ACPA titers in their sera 
were not included in this study since the focus was on ACPA levels present in SF of our 
cohort of RA patients, we demonstrated a higher synovialIgG-ACPA/total IgG ratio. This 
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was associated with a worse DAS-28 score, supporting the notion that ACPA production 
and/or retention at the site of inflammation have an impact on clinical manifestations [20]. 
The role of pro-inflammatory cytokines has extensively been described in RA [11, 21-22]. In 
our cohort of patients, we found a greater amount of IL-6 and IL-17 in the ACPA
high
 SF. IL-
17 is a well-known cytokine associated with the pathogenesis of RA [21], with higher levels 
in SF and also an increase prevalence of IL17
+
 cells in plasma of RA patients [23]. IL-17 is a 
strong inducer of inflammatory mediators in endothelial cells and fibroblasts, resulting in 
neutrophil recruitment [24]. Additionally, IL-6 is one of the key cytokine effectors of the 
tissue response in RA [21], also having important effects on the production of antibodies by 
B cells [25]. It was showed that IL-6 inhibition in ACPA-seropositive patients reduced bone 
loss, demonstrating that IL-6 have a negative impact on bone metabolism in the presence of 
ACPAs [26].  
IL-8/CXCL8, considered an important inflammatory chemokine associated with arthritis, 
chemoattract neutrophils and it is produced by macrophages, synovial lining cells, fibroblasts 
and endothelial cells [27]. It was shown that elevated IL-8 levels are present in the serum and 
SF of RA patients [27-28]. It was also reported that IL-8 levels are associated with clinical 
signs and symptoms of arthritis in synovial tissue of RA patients [29]; however, this 
relationship has not been tested according to the ACPA status. We demonstrated that synovial 
IL-8 levels showed a positive correlation with disease activity and also with SF-neutrophil 
counts when ACPAs were present in SF of RA patients. Although we did not test a 
relationship between IL-8 and neutrophil infiltration, we might speculate that this cytokine is 
partly responsible for the accumulation of neutrophils. Indeed, it was demonstrated that IL-8 
is involved in the migration of neutrophils into the inflamed joints [30]. Additionally, the 
association observed between IL-8 levels and disease severity could be related to increased 
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DNA extrusion. In fact, it was demonstrated that NET production induces increased 
production of IL-8 and IL-6 by synovial fibroblasts in RA [7]. 
In recent years, particular attention has been to the contribution of NET formation in the 
pathogenesis of RA disease [4, 7-8]. NET production results in exposure of intracellular self-
molecules that can serve as autoantigens. In fact, the generation of proteins modified by 
citrullination in the joint by activation of PADs is a key stage to trigger anticitrulline 
immunity in ACPA-positive patients [31]. Thus, NET formation is likely to play a pathogenic 
role in RA as NETosis may serve as an important source of citrullinated autoantigens[4]. 
Although this study involved a relatively low number of SF samples, we observed that in 
vitro incubation of neutrophils with ACPA
high
 SF resulted in an increase of ROS production 
in PMA-primed cells, and also in extracellular DNA release. It is important to notice that we 
only quantified extracellular DNA release, as this can be an indicative of NETosis. However, 
this could also be related to other neutrophil functions such as leukotoxic hypercitrullination 
[32]. Indeed, stimulation of neutrophils from healthy individuals with ACPA
high
SF but 
without PMA-priming showed an increased extracellular DNA release in the absence of ROS 
production. Nevertheless, this was not the case for neutrophils from RA patients, in which 
stimulation with ACPA
high 
SF showed an enhancement in DNA extrusion together with an 
increase in ROS production, but without the requirement of PMA-priming. While the process 
observed in neutrophils from healthy individuals would be indicative of leukotoxic 
hypercitrullination, in RA neutrophils DNA extrusion can be related to NETosis, because an 
increase in ROS was also observed [32]. It was reported that both circulating and SF-
neutrophils from RA patients show enhanced NET release, and this increase correlates with 
the presence and levels of ACPAs and with systemic inflammation [7]. An increased 
extrusion of DNA was only observed in RA neutrophils after incubation with ACPA
high
 SF 
but not in the case of stimulation with purified IgG from SF or with the fraction of SF without 
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IgG. This could result from the combination of elevated autoantibodies and IL-17, since this 
inflammatory cytokine was associated with enhanced NET release in RA [7].  
ICAM-1 is a key adhesion molecule that plays an important role in cell migration and 
intercellular interactions. ICAM-1 is generally absent or expressed at very low levels on 
circulating neutrophils [33], though elevated levels were reported in numerous infectious and 
inflammatory clinical settings [15, 33-34]. In a recent study, Woodfin et al. have shown that 
certain stimuli, such as LPS, can induce the expression of ICAM-1 on the cell surface of 
murine neutrophils [17]. This study also demonstrated that the expression of ICAM-1 
supported enhanced ROS generation and phagocytosis [17].We found that neutrophil 
incubation with ACPA
high 
SF induced a significant increase in the percentage of ICAM-1-
expressing neutrophils. To our knowledge, this is the first time that the ICAM-1 expression 
on neutrophils has been linked to autoantibodies, since previous reports had associated 
neutrophil ICAM-1 induction with the stimulants LPS, TNF and bacterial components [17, 
34]. It has been demonstrated that the induction of ICAM-1 in infectious settings supports 
phagocytosis and ROS generation, proposing it as an important molecule for pathogen 
clearance [17]. Although we did not measure phagocytic capability in our study, we might 
speculate that, after been recognized by FcγRs, synovial ACPA autoantibodies might 
stimulate phagocytosis. 
In conclusion, the data presented here shed new light on the function of synovial ACPAs and 
infiltrating neutrophils in perpetuating inflammation in RA. Besides, the subset of ICAM-
1positive neutrophils can be considered as a promising candidate biomarker of disease 
activity. Understanding the role of SF ACPAs on neutrophils in RA may open new 
perspectives to the treatment of this rheumatic disease. 
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Materials and Methods 
Ethics statement 
Experiments were performed in accordance with an internal review board-approved protocol 
at Instituto de Biología y Medicina Experimental (IBYME; Buenos Aires, Argentina; CE 
003-2/2013). All healthy donors and patients gave their written informed consent. 
Participants and synovial fluid samples 
Synovial fluid samples (SF) were obtained from 82 patients with RA and blood samples were 
obtained from 4 patients with RA and from 5 healthy individuals. The patients fulfilled the 
revised criteria proposed by the American College of Rheumatology/European League 
Against Rheumatism for RA [35-37]. Demographic and clinical characteristics of RA patients 
are included in Supplementary Table 1. The mean age of RA patients was 55 years old 
(range, 28-79 years old), and the mean duration of the disease was 7 years (range, 1–30 
years).Seventy-three RA patients were seropositive for Immunoglobulin (Ig) M rheumatoid 
factor (IgM RF). Patients (65females, 17males) were taking the following medications: non 
biologicaldisease-modifying antirheumatic drugs (nbDMARDs; n=67), or biological disease-
modifying antirheumatic drugs (bDMARDs; n=8).  
Synovial fluid was obtained after aspiration of knee joints, collected into heparinized tubes 
and centrifuged at 800 g for 5 min to remove the cells, which were used in flow cytometric 
analysis. The cell-free fluid was then centrifuged at 3,000 g for 10 min and the SF 
supernatant was stored at -20 °C until analysis. 
Antibodies and cytokine measurements on SF 
Before assay, each SF was treated with 1 mg/ml hyaluronidase (type IV-S, SIGMA-Aldrich, 
St. Louis, MO) for 30 min at 37°C followed by centrifugation (10,000 g, 5 min). IgGACPA 
levels (units) were determined by enzyme-linked immunosorbent assay (ELISA; Quanta Lite 
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CCP3 IgG ELISA, INOVA Diagnostics, San Diego, CA) according to the manufacturer’s 
instructions. SF from patients with other joint inflammation disorders (ankylosing 
spondylitis: n=3; osteoarthritis: n=9; psoriatic arthritis: n=8)were used to set the cut-off value 
of ACPA negativity (23 U/ml). Total synovial IgG levels were tested by radial 
immunodiffusion assay (IAC International SRL, Buenos Aires, Argentina). IgG from 4 
ACPA
high
 SF samples was isolated by affinity chromatography on Protein G Sepharose 4 Fast 
Flow column (GE Healthcare). Briefly, SF samples were diluted to 1:2 in PBS, dialyzed with 
binding buffer and then loading onto the column. Bound antibodies were eluted with 0.1 M 
Glycine-HCl and neutralized with Tris-HCl 1M. The isolated IgG and unbound fraction were 
then dialyzed against PBS. The concentration of interleukin (IL)-6, IL-17 (eBioscience, San 
Diego, CA), IL-8 (Immuno Tools GbmH, Friesoythe, Germany) was measured by ELISA 
following manufacturer’s instructions. The limits of detection were 4 pg/ml for IL-17, 2 
pg/ml for IL-6 and 3 pg/ml for IL-8. 
Cell isolation and stimulation 
Neutrophils were obtained from heparinized venous blood cells from healthy donors and 
were isolated using Percoll (GE Healthcare, Fairfield, CA, USA) density gradient as reported 
in Buckley et al. [33]. Contaminating erythrocytes were removed by hypotonic lysis. Cell 
population purity (>85%) was checked by flowcytometry analysis. Purified neutrophils were 
then incubated in the presence or absence of SF for 3 hours at 37 °C under 5% CO2 in 96-
well culture plates. 
Assessment of ROS production 
Oxidative stress biomarkers were analyzed in neutrophils using flow cytometry. For the 
assessment of ROS generation, neutrophils were first stimulated with SF and then incubated 
with Dihidro Rhodamine 123 (DHR; 1 µM; SIGMA-Aldrich) at 37 °C for 10 min. Next, cells 
were stimulated with phorbol-12-myristate-13-acetate (PMA; 200 ng/ml; SIGMA-Aldrich) 
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for 20 min at 37 °C and after incubation were then washed, re-suspended in PBS, and 
analyzed by flow cytometry[38]. DHR loaded unstimulated cells were used as control. DHR 
positive neutrophils were identified as cells with a higher DHR signal than control cells. 
Quantitative flourometric analysis of NET release 
Neutrophils (1 x 10
5
) were incubated in HBSS in 96-well plates with SF with the following 
reagents: PMA (an activator of NET formation), Triton X-100 (to determine total DNA 
content), DNase (2 U/µl; Promega), as appropriate, for 3 h at 37 °C. Release of extracellular 
DNA was detected by adding SYTOX Green Nucleic Acid Stain (2.5 µg/ml; Invitrogen Life 
Technologies, Carlsbad, CA). Fluorescence was measured using a fluorescence microplate 
reader (Perkin-Elmer LS 55, Perkin-Elmer, Waltham, MA) at 480 nm excitation, 520 nm 
emission. The data were normalized as percentage of total DNA, substracting the 
fluorescence intensity of the DNAse-containing wells from the comparative control, and 
dividing it by the fluorescence intensity emitted from cells treated with Triton X-100 (total 
DNA present) [39]. 
Flow cytometry 
Flow cytometric analysis was used to assess surface expression of CD16-FITC (clone B73.1), 
CD62L-PE (clone DREG-56), CXCR1-PerCp-Cy5 (clone G265-8), and CD54-APC (clone 
HA58) on in vitro-stimulated neutrophils from peripheral blood of healthy individuals and on 
SF-neutrophils from RA patients. All antibodies were from BD-Biosciences (San Jose, CA). 
Neutrophils were identified by their light scatter properties and by the expression of CD15-
FITC (clone HI98; BioLegend, Munich, Germany). Cell acquisitions were performed on a 
FACSCalibur flow cytometer (BD Biosciences) and data were analyzed using the CellQuest 
software (BD Biosciences) or the FlowJo software (TreeStar Inc., CA). 
Statistical analysis 
Nonparametric one-way analysis of variance (Kruskal–Wallis test) followed by Dunn’s post-
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hoc test were used to compare multiple groups. The nonparametric Student’s t test (Mann 
Whitney) was performed for two experimental groups. Correlation was assessed by the 
Spearman’s correlation coefficient. Analyses were performed using GraphPad Prism version 
5.00 (GraphPad Software, La Jolla, CA, USA). P-value less than 0.05 was regarded as 
significant. 
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Figure Legends: 
Figure 1.Relationship among disease activity, neutrophil counts and ACPA levels in SF of RA 
patients. SF samples were tested for the presence of ACPA autoantibodies and grouped 
forACPA-positive or ACPA-negative patients. A) The scatter plot shows the median and the 
interquartile range of neutrophil counts in SF of ACPA-positive (n=42) and ACPA-negative 
patients (n=21); the correlation analysis between the number of neutrophils in SF and DAS-
28 in both groups is also shown. B) Graphs show correlation between IgG levels and DAS-28 
(n=32) and ACPA-IgG in relation to total IgG (arbitrary units (U)/mg IgG) and DAS-28 in 
SF samples of ACPA-positive patients (n=42). A,B) Statistical analysis was performed with 
Mann Whitney test and Spearman correlation test. Data are pooled from at least 7 
independent experiments with minimum 3 RA patients per experiment. 
 
  
  
 
This article is protected by copyright. All rights reserved. 
22 
 
 
Figure 2.Increased levels of IL-6, IL-17 and IL-8 in ACPA
high
 SF.A) SF samples were 
grouped according to the levels of ACPA autoantibodies into negative (open circles; <25 
U/ml), low (gray square; 25-200 U/ml) and high (filled circle; >200 U/ml). Levels of IL-6 
(n=86), IL-17 (n=72) and IL-8 (n=78) were then measured by ELISA. The median 
concentration of each cytokine is represented by a horizontal bar. Between-group 
comparisons were performed using the Kruskal Wallis test with Dunn’s multiple comparison 
post hoc test. *p<0.05. B) Correlation between IL-8 and neutrophil counts, and between 
DAS-28 and IL-8 levels in patients with high ACPA levels. Spearman correlation test was 
used to calculate the correlation coefficient (r) and p-value; n=37. A, B) Data are pooled from 
at least 4 independent experiments with minimum 9 RA patients per experiment. 
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Figure 3. Neutrophils stimulated with ACPA
high
 SF produced higher ROS and extracellular 
DNA release. Peripheral-blood neutrophils from healthy donors were incubated in the 
presence of SF from RA patients with negative-, low- or high-ACPA levels. A, B) ROS 
production was assessed by measuring DHR fluorescence in the presence (PMA-stimulated; 
n=26) or absence (unstimulated; n=21) of PMA using flow cytometry. The graph shows the 
average DHR fluorescence of neutrophils stimulated with SF with negative-, low- or high-
ACPA levels after stimulation or with no stimulation with PMA. Representative histograms 
of isotype control and each group of SFs are also shown.The percentage of increase in ROS 
production over control is also shown.C) Quantitative fluorometric analysis with SYTOX 
Green of neutrophil extracellular DNA release after being stimulated by SF from RA patients 
with negative-, low- or high-ACPA levels for 3 hours. The data were normalized as 
percentage of total DNA of each condition; n= 39.A, B, C) Data represent mean + SD. At 
least 3 independent experiments were performedwhereperipheral-blood from 2 healthy 
individuals and 6-9 RA SF samples were used per experiment. Between-group comparisons 
were performed using the Kruskal Wallis test with Dunn’s multiple comparison post hoc test. 
*p<0.05; **p<0.01. 
 
Figure 4. The frequency of ICAM-1
positive
 neutrophils is related to levels of synovial ACPAs. 
A) Peripheral-blood neutrophils from healthy donors were incubated or not incubated (basal) 
with SF from RA patients with negative-, low- or high-ACPA levels, and their phenotype was 
analyzed by flow cytometry. The graph shows the percentage of ICAM-1-positive neutrophils 
(as percentage of CD16
bright
FSC
high
SSC
high
 cells).Representative histograms of isotype control 
(shaded) and each group of patients (non-shaded) are also shown. B) Flow cytometry analysis 
of cell-surface expression of CD62L and CXCR1 of basal (peripheral-blood neutrophils) and 
ICAM-1
positive
 neutrophils from SF of RA patients with negative-, low- and high-ACPA 
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levels. A, B) Between-group comparisons were performed using the Kruskal Wallis test with 
Dunn’s multiple comparison post hoc test. *p<0.05; **p<0.01; ***p<0.001. Data represent 
mean +SD. n= 16.C) Positive correlation between the percentage of ICAM-1
positive
 
neutrophils and extracellular DNA release in neutrophils stimulated with SF from patients 
with high ACPA levels. Spearman correlation test was used to calculate the correlation 
coefficient (r) and p-value. n= 14.A, B, C) Data are pooled from at least 4 independent 
experiments where peripheral-blood from 2 healthy individuals and 6-9 RA SF samples were 
used per experiment. 
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Figure 5.ICAM-1
positive 
neutrophils in vivo. A) SF samples of RA patients were analyzed by 
flow cytometry for the identification of ICAM-1
positive 
neutrophils. The graph shows the 
percentage, as quantified by flow cytometry, of ICAM-1
positive
 neutrophils (as percentage of 
CD16
bright 
FSC
high
SSC
high
 cells) in SF of patients with negative-, low- and high-ACPA levels. 
Data are represented in a box and whisker diagram which shows the interquartile range, 
median and minimum and maximum. Representative histograms of isotype control (shaded) 
and each group of patients (non-shaded) are also shown. B) Flow cytometry analysis of cell-
surface expression of CD62L and CXCR1 of basal (peripheral-blood neutrophils) and ICAM-
1
positive
 neutrophils from SF with negative-, low- and high-ACPA levels. Data represent mean 
+ SD. A, B) Between-group comparisons were performed using the Kruskal Wallis test with 
Dunn’s multiple comparison post hoc test. *p<0.05; **p<0.01; ***p<0.001. n= 17. Data are 
pooled from at least 6 independent experiments with 1-3 RA patients per experiment. 
 
 
  
  
 
This article is protected by copyright. All rights reserved. 
26 
 
 
In rheumatoid arthritis (RA), the presence or absence of anti-citrullinated peptide antibodies 
(ACPAs) can define different disease entities. We analyze the characteristics of synovial 
neutrophils in the presence of different synovial levels of ACPAs and provide insight into the 
association of synovial ACPA titers and local inflammation in RA patients.  
 
 
